Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa
<p><strong> Background</strong></p> Dexamethasone and remdesivir have the potential to reduce coronavirus disease 2019 (COVID)–related mortality or recovery time, but their cost-effectiveness in countries with limited intensive care resources is unknown. <p><strong&...
Príomhchruthaitheoirí: | , , , , , , , , , |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Oxford University Press
2021
|